chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Rash erythematous, Reticulocyte count, Skin warm
Clinical narrative: Shortly after receiving the vaccine I became very itchy, mostly on my back at first, then all over. I developed a rash between my shoulder blades by the spring of 2022. The rash spread to my whole torso and became red, hot and inflamed. The doctors thought it was an allergic reaction or contact dermatitis. Eventually I got a biopsy in March of 2023. It came back positive for Cutaneous T-Cell Lymphoma. I later had more testing done and I also have blood and bone marrow involvement at low levels. I see a Dermapathologist and an oncologist regularly and have currently failed all non-systemic treatments. I have recently started Methotrexate. It is helping  but hasn?t cleared yet, they are going to up my dose in a few weeks.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: T-cell receptor gene rearrangement test, Treatment failure
Clinical narrative: Shortly after receiving the vaccine I became very itchy, mostly on my back at first, then all over. I developed a rash between my shoulder blades by the spring of 2022. The rash spread to my whole torso and became red, hot and inflamed. The doctors thought it was an allergic reaction or contact dermatitis. Eventually I got a biopsy in March of 2023. It came back positive for Cutaneous T-Cell Lymphoma. I later had more testing done and I also have blood and bone marrow involvement at low levels. I see a Dermapathologist and an oncologist regularly and have currently failed all non-systemic treatments. I have recently started Methotrexate. It is helping  but hasn?t cleared yet, they are going to up my dose in a few weeks.
Age: 5.0
Sex: M
Vaccine: FLUC4, MMRV, UNK
Symptoms: Product storage error
Clinical narrative: No adverse event; Improper storage of product in use; This spontaneous report was received from a registered nurse and refers to a 5-year-old male patient.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Flucelvax quadrivalent (Influenza vaccine inact sAg 4v). On 01-OCT-2024, the facility received a shipment of COVID vaccine that needed to be stored in the freezer. There was no room in the freezer to accommodate the shipment. It was assumed that the Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) received could be stored in both the freezer and refrigerator and both state and private Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) were moved to the refrigerators where they remained within normal refrigerated temperature range until administration. The dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) administered to the client arrived at facility on 13-NOV-2024 and was stored in the refrigerator until administered on 18-DEC-2024.  On 18-DEC-2024, the patient was vaccinated with the second dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013579, expiration date: 03-Feb-2026), administered by Subcutaneous route in Left Thigh (exact dose was not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiry dates were not provided) (improper storage of product in use). No additional adverse event reported (no adverse event).  This case was one of several reports received from the same reporter with the case US-009507513-2254349.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : @merck.com , Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 12/XX/2018 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :
Age: 5.0
Sex: M
Vaccine: FLUC4, MMRV, UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse event; Improper storage of product in use; This spontaneous report was received from a registered nurse and refers to a 5-year-old male patient.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Flucelvax quadrivalent (Influenza vaccine inact sAg 4v). On 01-OCT-2024, the facility received a shipment of COVID vaccine that needed to be stored in the freezer. There was no room in the freezer to accommodate the shipment. It was assumed that the Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) received could be stored in both the freezer and refrigerator and both state and private Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) were moved to the refrigerators where they remained within normal refrigerated temperature range until administration. The dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) administered to the client arrived at facility on 13-NOV-2024 and was stored in the refrigerator until administered on 18-DEC-2024.  On 18-DEC-2024, the patient was vaccinated with the second dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013579, expiration date: 03-Feb-2026), administered by Subcutaneous route in Left Thigh (exact dose was not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiry dates were not provided) (improper storage of product in use). No additional adverse event reported (no adverse event).  This case was one of several reports received from the same reporter with the case US-009507513-2254349.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : @merck.com , Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 12/XX/2018 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :
Age: 12.0
Sex: M
Vaccine: COVID19, FLU4, HEP, HEPA, HPV9, IPV, MMRV, TDAP, HEP, HEPA, HPV9, UNK
Symptoms: Product storage error
Clinical narrative: no adverse event; incorrect product storage; This spontaneous report was received from an Nurse and refers to a(n) 12-year-old male patient.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Historical drugs included Ipol (Polio vaccine inact 3v (Vero)) (IPOL), quadrivalent (Influenza vaccine inact split 4v) (FLUARIX), (Diphtheria vaccine toxoid;Pertussis vaccine acellular 3-component;Tetanus vaccine toxoid)(BOOSTRIX), and COVID-19 vaccine (COVID-19 vaccine). Concomitant therapies were not reported.   On 08-Jan-2025, the patient was vaccinated with following vaccines: Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #X024650, expiration date: 31-May-2026) administered by Intramuscular route in Right Arm ; Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013579, expiration date: 03-Feb-2026) administered by Subcutaneous route in Right Arm; (Hepatitis a vaccine inact)(HAVRIX) (lot #T5727) (left arm), administered by Intramuscular route (expiration date was not reported) and Hepatitis b vaccine rHBsAg (yeast))(ENGERIX B) (lot #95BJ9) (right arm), administered by Subcutaneous route (expiration date was not reported). All vaccines were administered for prophylaxis.  Patients received improperly stored PROQUAD since it was stored in the refrigerator for months instead of the freezer. The patient experienced no adverse event.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 03/31/2012 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :
Age: 12.0
Sex: M
Vaccine: COVID19, FLU4, HEP, HEPA, HPV9, IPV, MMRV, TDAP, HEP, HEPA, HPV9, UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse event; incorrect product storage; This spontaneous report was received from an Nurse and refers to a(n) 12-year-old male patient.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Historical drugs included Ipol (Polio vaccine inact 3v (Vero)) (IPOL), quadrivalent (Influenza vaccine inact split 4v) (FLUARIX), (Diphtheria vaccine toxoid;Pertussis vaccine acellular 3-component;Tetanus vaccine toxoid)(BOOSTRIX), and COVID-19 vaccine (COVID-19 vaccine). Concomitant therapies were not reported.   On 08-Jan-2025, the patient was vaccinated with following vaccines: Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #X024650, expiration date: 31-May-2026) administered by Intramuscular route in Right Arm ; Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013579, expiration date: 03-Feb-2026) administered by Subcutaneous route in Right Arm; (Hepatitis a vaccine inact)(HAVRIX) (lot #T5727) (left arm), administered by Intramuscular route (expiration date was not reported) and Hepatitis b vaccine rHBsAg (yeast))(ENGERIX B) (lot #95BJ9) (right arm), administered by Subcutaneous route (expiration date was not reported). All vaccines were administered for prophylaxis.  Patients received improperly stored PROQUAD since it was stored in the refrigerator for months instead of the freezer. The patient experienced no adverse event.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 03/31/2012 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :
Vaccine: MMR, MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event; Expired vaccine used; Information has been received from Business Partner/CRO on 12-Feb-2025.  This spontaneous report was received from a/an Other health professional and refers to a(n) patient of unknown age and gender.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On an unknown date, the patient started therapy with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (lot #X004346, expiration date: 08-Feb-2025) (0.5ml SQ),. On an unknown date, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), (lot # and expiration date were not reported). The patient started therapy with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), for the treatment of prophylaxis.  The patient started therapy with sterile diluent (MERCK STERILE DILUENT), for the treatment of prophylaxis.  On 12-Feb-2025, the patient experienced Expired vaccine used. On an unknown date, the patient experienced no adverse event.   At the reporting time, the outcome of Expired vaccine used was unknown.   The action taken with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live was reported as not applicable.
Age: 28.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Erythema, Hyperhidrosis, Palpitations
Clinical narrative: PATIENT CAME IN FOR FLU VACCINE. HAD AN ADVERSE REACTION OF HEART PAPITATIONS, TIGHTNESS IN THE CHEST, REDNESS OF FACE AND SWEATING. HE WAS ABLE TO SIT FOR OBSERVATION FOR 45 MINUTES AND STILL EXPERIENCED SAME REACTIONS. EMERGENCY TEAM WAS CALLED FOR ASSISTANCE AND TRANSPORTED PATIENT TO EMERGENCY ROOM.
Age: 28.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Chest discomfort, Erythema, Hyperhidrosis, Palpitations
Clinical narrative: PATIENT CAME IN FOR FLU VACCINE. HAD AN ADVERSE REACTION OF HEART PAPITATIONS, TIGHTNESS IN THE CHEST, REDNESS OF FACE AND SWEATING. HE WAS ABLE TO SIT FOR OBSERVATION FOR 45 MINUTES AND STILL EXPERIENCED SAME REACTIONS. EMERGENCY TEAM WAS CALLED FOR ASSISTANCE AND TRANSPORTED PATIENT TO EMERGENCY ROOM.
Age: 24.0
Sex: F
Vaccine: TDAP
Symptoms: Exposure during pregnancy, Inappropriate schedule of product administration
Clinical narrative: There were two patients that were pregnancy. First patient was 28 week and the next patient was 23 weeks and 5 days. MA was notified to give the 28 weeks patient a TDAP but the MA was gave the 23 weeks and 5 day patient the TDAP. Patient was notified about the vaccine and was given a VIS SHEET as well.
Age: 24.0
Sex: F
Vaccine: MMR
Symptoms: Coma, Decreased appetite, Fatigue, Glossodynia, Headache
Clinical narrative: Day 14 (onset of symptoms): Developed swollen and painful lymph nodes (primarily in left groin and abdominal area, some in neck and collarbone).  ? Day 15-16 (worsening symptoms):  ? Low-grade fever (persisting for over 24 hours).  ? Fatigue and loss of appetite, worsened by waves of sudden, intense nausea.  ? Vomiting, causing a heart rate spike to 155 bpm  ? Blurred vision in the left eye (same side as the vaccine), lasting an entire day and unresponsive to hydration/rest.  ? Pressure headache behind the eyes, improved with Tylenol.  ? Sore throat likely due to swollen lymph nodes.  ? Mouth sores on the left side, on tongue and soft palate
Age: 24.0
Sex: F
Vaccine: MMR
Symptoms: Heart rate increased, Lymph node pain, Lymphadenopathy, Nausea, Oropharyngeal pain
Clinical narrative: Day 14 (onset of symptoms): Developed swollen and painful lymph nodes (primarily in left groin and abdominal area, some in neck and collarbone).  ? Day 15-16 (worsening symptoms):  ? Low-grade fever (persisting for over 24 hours).  ? Fatigue and loss of appetite, worsened by waves of sudden, intense nausea.  ? Vomiting, causing a heart rate spike to 155 bpm  ? Blurred vision in the left eye (same side as the vaccine), lasting an entire day and unresponsive to hydration/rest.  ? Pressure headache behind the eyes, improved with Tylenol.  ? Sore throat likely due to swollen lymph nodes.  ? Mouth sores on the left side, on tongue and soft palate
Age: 24.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Stomatitis, Vision blurred
Clinical narrative: Day 14 (onset of symptoms): Developed swollen and painful lymph nodes (primarily in left groin and abdominal area, some in neck and collarbone).  ? Day 15-16 (worsening symptoms):  ? Low-grade fever (persisting for over 24 hours).  ? Fatigue and loss of appetite, worsened by waves of sudden, intense nausea.  ? Vomiting, causing a heart rate spike to 155 bpm  ? Blurred vision in the left eye (same side as the vaccine), lasting an entire day and unresponsive to hydration/rest.  ? Pressure headache behind the eyes, improved with Tylenol.  ? Sore throat likely due to swollen lymph nodes.  ? Mouth sores on the left side, on tongue and soft palate
Age: 0.67
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Injection site erythema
Clinical narrative: Redness at injection site with 1.5 induration.
Age: 51.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Diarrhoea, Fatigue, Muscular weakness, Myalgia
Clinical narrative: Severe muscle soreness, muscle weakness, diarrhea, severe fatigue
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Immediate post-injection reaction, Injected limb mobility decreased, X-ray limb
Clinical narrative: Covid vaccine administered 09/12/24 into left deltoid by RPh per Vaccine Admin Record.   PER 10/29/2024 CHART NOTE: "She also reports a new onset of left lateral shoulder pain that began immediately after receiving a COVID-vaccine 7 weeks ago that she feels was placed too high.  This pain is constant aggravated by overhead activities on the left side." PER 2/18/25 CHART NOTE: "possible component of subacromial impingement and suspected partial thickness rotator cuff tear significant improvement after left subacromial steroid injection 10/29/2024 with recurrence of symptoms."
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Magnetic resonance imaging abnormal, Mobility decreased, Pain, Tendon disorder
Clinical narrative: Covid vaccine administered 09/12/24 into left deltoid by RPh per Vaccine Admin Record.   PER 10/29/2024 CHART NOTE: "She also reports a new onset of left lateral shoulder pain that began immediately after receiving a COVID-vaccine 7 weeks ago that she feels was placed too high.  This pain is constant aggravated by overhead activities on the left side." PER 2/18/25 CHART NOTE: "possible component of subacromial impingement and suspected partial thickness rotator cuff tear significant improvement after left subacromial steroid injection 10/29/2024 with recurrence of symptoms."
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tendon rupture
Clinical narrative: Covid vaccine administered 09/12/24 into left deltoid by RPh per Vaccine Admin Record.   PER 10/29/2024 CHART NOTE: "She also reports a new onset of left lateral shoulder pain that began immediately after receiving a COVID-vaccine 7 weeks ago that she feels was placed too high.  This pain is constant aggravated by overhead activities on the left side." PER 2/18/25 CHART NOTE: "possible component of subacromial impingement and suspected partial thickness rotator cuff tear significant improvement after left subacromial steroid injection 10/29/2024 with recurrence of symptoms."
Age: 35.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered
Clinical narrative: Member was given an extra dose of the Influenza vaccine on 3/13/25.  Member is a new patient with clinic/facility and came in asking for a Flu shot.  After releasing the available order in our system and giving the member the vaccine, I realized that the member had already received the Influenza vaccine outside of our facility on 2/5/25 (found after reviewing outside records in his medical record).   Member received numerous vaccines outside of our facility on 2/5/25.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Expired product administered
Clinical narrative: Patient was given vaccine on 3/13/25 but vaccine had expired on 3/4/25
Age: 90.0
Sex: M
Vaccine: PNC20
Symptoms: Extra dose administered
Clinical narrative: Patient received vaccine in 2024, patient was given unnecessary additional dose of vaccine in 2025
Age: 4.0
Sex: M
Vaccine: HEPA, MMRV
Symptoms: Urticaria
Clinical narrative: urticaria
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Death, Dysphagia
Clinical narrative: Passed away while on hospice care for diagnosis: Dyphasia following CVA
Age: 49.0
Sex: F
Vaccine: RAB
Symptoms: Asthenia, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: The donor disclosed that on 02/20/25 after the Rabies immunization was received, later that night she started having low fever (100.1 C), chills, loss of appetite, fatigue, weakness and headache. She stated that the following day, she had the same symptoms and vomiting. Donor then went to an Urgent Care to seek medical attention. There she was prescribed Tylenol for the symptoms and was tested for Influenza and respiratory infections with negative results. Symptoms describe above persisted for 3 days.
Age: 49.0
Sex: F
Vaccine: RAB
Symptoms: Influenza virus test negative, Laboratory test normal, Pyrexia, Vomiting
Clinical narrative: The donor disclosed that on 02/20/25 after the Rabies immunization was received, later that night she started having low fever (100.1 C), chills, loss of appetite, fatigue, weakness and headache. She stated that the following day, she had the same symptoms and vomiting. Donor then went to an Urgent Care to seek medical attention. There she was prescribed Tylenol for the symptoms and was tested for Influenza and respiratory infections with negative results. Symptoms describe above persisted for 3 days.
Age: 71.0
Sex: M
Vaccine: PNC20
Symptoms: Extra dose administered
Clinical narrative: PATIENT RECEIEVED VACCINE IN 2024. VACCINE GIVEN IN 2025 WAS NOT NEEDED
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Syncope
Clinical narrative: Patient fainted after receiving HPV vaccine.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injection site pain, Joint range of motion decreased, Joint stiffness, Product administered at inappropriate site
Clinical narrative: At time of injection, there was more pain that past experiences. Noticed that injector placed bandaid very high on top of shoulder after injection. Soreness was immediate and progressively got worse with pain during any movement, stiffness of joint, loss of range of motion. OTC medications were taken to ease pain. This continued for 2 months with no improvement of symptoms. Saw an orthopedic surgeon that gave one dose of steroid injection into joint. This relieved pain for 2 weeks. Pain returned after that and has not improved. Pain continues with passive movement. Pain during sleep. Unable to lay on left shoulder due to pain.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aspiration bone marrow, Blood iron, Blood uric acid, Full blood count, Janus kinase 2 mutation
Clinical narrative: Exactly a year after my fourth covid vaccine my platelet count started to increase.  In April, 2024, I was diagnosed with essential thrombocytopenia and in May 2024 I tested positive for the JAK 2 gene.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Platelet count increased, Serum ferritin, Thrombocytopenia
Clinical narrative: Exactly a year after my fourth covid vaccine my platelet count started to increase.  In April, 2024, I was diagnosed with essential thrombocytopenia and in May 2024 I tested positive for the JAK 2 gene.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gene mutation identification test positive, Janus kinase 2 mutation, Platelet count, Platelet count increased, Thrombocytopenia
Clinical narrative: Exactly a year after my fourth covid vaccine my platelet count started to increase.  In April, 2024, I was diagnosed with essential thrombocytopenia and in May 2024 I tested positive for the JAK 2 gene.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Heart rate decreased, Irritability, Pain of skin, Pyrexia, Rash
Clinical narrative: Fever of 103.5 for 3 days, full body rash for 4 days, cranky and irritable, skin hurt to touch, lower heart rate when sleeping
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, C-reactive protein increased, Chest discomfort, Colitis ulcerative, Condition aggravated
Clinical narrative: I began having chest pressure daily starting on the day of vaccination (10/14/21) along with palpitations. It lasted for about 10 minute intervals and caused anxiety and elevated heart rate. I also had multiple flare ups of my ulcerative colitis that was well controlled prior to this vaccination. One of these flares required hospitalization on March 3rd, 2024. My labs from 3/4/2024 included a CRP of 137, ESR of 40, WBC of 15.9, Neutrophils 85.3, Neutrophils absolute 13.59, Lymphocytes 7.9. on 3/6/24 my platelets were 389. All of these numbers showing a high level of systemic inflammation in my body.  I still get chest pressure and palpitations at least occurring once a month since vaccination. Also, I have chronic pain in my left arm from my shoulder to my elbow in the same arm I was vaccinated in. This still occurs today, and is constant 3/10 pain. I get no relief from analgesics.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Injection site pain, Lymphocyte percentage decreased, Neutrophil count increased, Neutrophil percentage increased
Clinical narrative: I began having chest pressure daily starting on the day of vaccination (10/14/21) along with palpitations. It lasted for about 10 minute intervals and caused anxiety and elevated heart rate. I also had multiple flare ups of my ulcerative colitis that was well controlled prior to this vaccination. One of these flares required hospitalization on March 3rd, 2024. My labs from 3/4/2024 included a CRP of 137, ESR of 40, WBC of 15.9, Neutrophils 85.3, Neutrophils absolute 13.59, Lymphocytes 7.9. on 3/6/24 my platelets were 389. All of these numbers showing a high level of systemic inflammation in my body.  I still get chest pressure and palpitations at least occurring once a month since vaccination. Also, I have chronic pain in my left arm from my shoulder to my elbow in the same arm I was vaccinated in. This still occurs today, and is constant 3/10 pain. I get no relief from analgesics.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Platelet count normal, Red blood cell sedimentation rate increased, White blood cell count increased
Clinical narrative: I began having chest pressure daily starting on the day of vaccination (10/14/21) along with palpitations. It lasted for about 10 minute intervals and caused anxiety and elevated heart rate. I also had multiple flare ups of my ulcerative colitis that was well controlled prior to this vaccination. One of these flares required hospitalization on March 3rd, 2024. My labs from 3/4/2024 included a CRP of 137, ESR of 40, WBC of 15.9, Neutrophils 85.3, Neutrophils absolute 13.59, Lymphocytes 7.9. on 3/6/24 my platelets were 389. All of these numbers showing a high level of systemic inflammation in my body.  I still get chest pressure and palpitations at least occurring once a month since vaccination. Also, I have chronic pain in my left arm from my shoulder to my elbow in the same arm I was vaccinated in. This still occurs today, and is constant 3/10 pain. I get no relief from analgesics.
Age: 26.0
Sex: F
Vaccine: HEP, HEP
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse symptoms noted at time of administration.
Age: 74.0
Sex: M
Vaccine: PNC20
Symptoms: Extra dose administered
Clinical narrative: none, but duplicate vaccine last given 03/14/2023
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Hyperhidrosis, Injection site pain, Presyncope, Unresponsive to stimuli
Clinical narrative: Patient reported pain upon injection of dissolved Shingrix liquid in the vaccine room and I had him report to the consultation window for information on the booster date and observation.  As I discussed the date range for 2-6 months he closed his eyes, leaned toward the consultation window and did not respond to verbal greeting. I ran out to him and had him sit down. I asked if he had breakfast and drank water today. He reported he had had breakfast but had not drank water for 1-2 days, just coffee that made him void. The blood pressure cuff from the vaccine room did not produce a value upon 3 attempts so a floor wrist BP monitor was utilized which also did not show a value.  I told him there was sweat on his brow. He called his wife and she said she would come. I asked her to bring a BG monitor because his BP could be low, his BP was being measures and he could be having an allergic reaction. A bottle of water was given with 2 Hershey kiss candies..  Patient reported a lump in his throat, no chest, arm or neck pain, blurring vision and a headache.  Paramedics were called. After the second water bottle was given with more chocolate I called his wife again. She was headed to the hospital, per her text but we notified her that we were still waiting for the paramedics.  She said she would come to the pharmacy   When the paramedics arrived I reported his symptoms with him. He was verbal, conscious. alert and oriented.  This headache and blurred vision were improving and he was able to open his eyes again. Paramedics reported low BP about 70/50 and normal BG about 120.  Paramedics had his care under control so I returned to the pharmacy for the care of other patients.  Patient left with the paramedics.  Called MD office spoke with medical assistant. Noted if he wants the 2nd Shringx vaccine and it is determined to not be an allergic reaction, he should get it at the MD office rather than the pharmacy.   6:20PM Called ER. He had been discharged. He did not answer his cell phone but ER released wife's cell phone. She said he is home and fine. It was a vasovagal reaction (suspected).
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Vision blurred
Clinical narrative: Patient reported pain upon injection of dissolved Shingrix liquid in the vaccine room and I had him report to the consultation window for information on the booster date and observation.  As I discussed the date range for 2-6 months he closed his eyes, leaned toward the consultation window and did not respond to verbal greeting. I ran out to him and had him sit down. I asked if he had breakfast and drank water today. He reported he had had breakfast but had not drank water for 1-2 days, just coffee that made him void. The blood pressure cuff from the vaccine room did not produce a value upon 3 attempts so a floor wrist BP monitor was utilized which also did not show a value.  I told him there was sweat on his brow. He called his wife and she said she would come. I asked her to bring a BG monitor because his BP could be low, his BP was being measures and he could be having an allergic reaction. A bottle of water was given with 2 Hershey kiss candies..  Patient reported a lump in his throat, no chest, arm or neck pain, blurring vision and a headache.  Paramedics were called. After the second water bottle was given with more chocolate I called his wife again. She was headed to the hospital, per her text but we notified her that we were still waiting for the paramedics.  She said she would come to the pharmacy   When the paramedics arrived I reported his symptoms with him. He was verbal, conscious. alert and oriented.  This headache and blurred vision were improving and he was able to open his eyes again. Paramedics reported low BP about 70/50 and normal BG about 120.  Paramedics had his care under control so I returned to the pharmacy for the care of other patients.  Patient left with the paramedics.  Called MD office spoke with medical assistant. Noted if he wants the 2nd Shringx vaccine and it is determined to not be an allergic reaction, he should get it at the MD office rather than the pharmacy.   6:20PM Called ER. He had been discharged. He did not answer his cell phone but ER released wife's cell phone. She said he is home and fine. It was a vasovagal reaction (suspected).
Age: 17.0
Sex: F
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Hepsilav B administered. Upon documentation of Hepsilav , flagged that should only be used in 18 years and older adults. Discussed with provider and practice manager. Provider notified patient. Practice manager notified parent (mother).
Age: 22.0
Sex: M
Vaccine: MMR
Symptoms: Bursitis, Pain, Swelling
Clinical narrative: Two days after the MMR 1 Vaccine was administered, Bursitis began developing in the right arm. Over the next two days, the Bursitis increased in pain and swelling.
Age: 72.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Mobility decreased
Clinical narrative: patient states she is unable to move her LEFT arm appropriately.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Vomiting
Clinical narrative: Vomiting twice morning after getting vaccine
Age: 0.5
Sex: M
Vaccine: DTPPVHBHPB, PNC20, RV5
Symptoms: Injection site nodule
Clinical narrative: Patient has had no previous reactions to vaccines. Left leg had localized small hard nodule within 1.5 hours of Vaxelis. Right leg had localized small hard nodule within 4 hours of PCV20. Patient was sore. Normal vaccine reactions except patient has not had this previously occur and has received the same vaccines in the past but with different lot numbers.
Age: 62.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Pharmacy administered a second RSV vaccine because patient did not remember previously receiving on in September 2023.  Patient has two shot records and confirmed both are his (current address and previous address) and pharmacy only pulled up his older one at time of administration.  Patient has not experienced any adverse events and says he feels fine.
Age: 40.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthritis
Clinical narrative: Severe, completely debilitating,  polyarticular inflammatory arthritis that was resistant to high dose NSAIDs and steroids. Has lasted >2 weeks.  He has been on dexamethasone 6mg 2x daily with gradual improvement in symptoms.
Age: 29.0
Sex: F
Vaccine: TDAP
Symptoms: Wrong product administered
Clinical narrative: Administration error in that this employee was given TDap vaccine instead of her second Hepatitis B vaccine.  Nurse administering the vaccine, noted it after she administered it.  had last dose of TDAp in 2022.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMRV
Symptoms: Extra dose administered, Nausea, No adverse event
Clinical narrative: patient did not have any Adverse events but was given 3 doses of DTAP-IPV (KINRIX) and MMRV (PROQUAD). Second dose was given on 10/09/2024 and third dose given on 03/11/2025. Mother to patient is worried about any reactions. Patient has not had any adverse reactions at this time. Patient was diagnosed with influenza on 03/10/2024. No  severe symptoms were ongoing at the time of vaccine. patient was prescribed Ondansetron was prescribed for nausea. We have informed mom we will report the extra vaccination. There are no adverse events at this time from the vaccines given.
Age: 54.0
Sex: F
Vaccine: HEP
Symptoms: Mobility decreased, Shoulder injury related to vaccine administration
Clinical narrative: SIRVA within 24 hours of injection; treated initially w NSAIDs.  Unable to move arm at 48 hours so escalated to prednisolone 30mg  daily x 5 days
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 1.42
Sex: M
Vaccine: MMR
Symptoms: Attention deficit hyperactivity disorder, Autism spectrum disorder, Fine motor delay, Gross motor delay, Laboratory test
Clinical narrative: Fevers of 106 degrees.  Taken to 3 ERs, (admitted for 11 days).  Currently having ADHD symptomology, delays in fine motor and gross motor skills, and some austistic features.
Age: 1.42
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Fevers of 106 degrees.  Taken to 3 ERs, (admitted for 11 days).  Currently having ADHD symptomology, delays in fine motor and gross motor skills, and some austistic features.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 63.0
Sex: M
Vaccine: PNC20
Symptoms: Extra dose administered
Clinical narrative: Patient insurance alerted to a duplicate paid claim from 02/01/2023 for prevnar 20. Patient didn't remember receiving in the past but accidentally got a second dose of vaccine.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 3.0
Sex: M
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccine given to early.
Age: 0.75
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid infection with hospitalization after vaccination
Age: 68.0
Sex: F
Vaccine: PNC20, TDAP
Symptoms: Extra dose administered, No adverse event, Wrong patient
Clinical narrative: This patient was given the Prevnar20 and Boostrix vaccine under the account of another person who has a very similar name. The vaccines were processed and given under the wrong patient's profile. The patient who received the vaccines was actually due for the Boostrix vaccine but not for the Prevnar20 because she has already received it. The mistake was realized when we recommended these vaccines to a patient. The patient stated that she had already received a few weeks prior. We could not find it on her profile since it was processed for the wrong patient with a similar name. After investigating, we were able to locate the consent form that showed we gave the vaccines to the incorrect patient. The patient was advised and informed of the mistake. Has not experienced any adverse reactions.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Extra dose administered
Clinical narrative: Client received 24/25 high dose trivalent flu vaccine at pharmacy on 8/20/24. Client to this clinic on 9/19/24 for 2nd vaccination. 2nd dose of vaccine was given without knowledge of receiving the first dose on 8/20/24.
Age: 17.0
Sex: M
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: CLIENT IS A 17-YEAR-OLD MALE.  HE RECEIVED A 1.0 CC ADULT DOSE OF HEPATITIS A VACCAINE RATHER THAN THE 0.5CC HEPATITIS A CHILD DOSE
Age: 19.0
Sex: F
Vaccine: HEP
Symptoms: Incorrect dose administered
Clinical narrative: Pt given one 1mL dose of Hep b instead of 0.5mL dose.
Age: 11.0
Sex: M
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Patient was given menB when he was supposed to get MenQuadValent. Patient is going to be scheduled for the correct vaccine.
Age: 67.0
Sex: F
Vaccine: PNC20
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event occurred pt feels fine. Pt had previously received a shot on 9/29/22.
Age: 1.25
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient given 3rd dose of seasonal influenza vaccine in error, only required 2 doses of vaccination for 2024-2025 season as this was the patient's first time receiving the flu vaccine. No known adverse effects/side effects from erroneous administration.
Age: 63.0
Sex: M
Vaccine: PNC21
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Pt received CAPVAXIVE on Feb. 13th 2025. Pt received second dosing of CAPVAXIVE on MArch 14th 2025. CAPVAXIVE is a one time dose. Medical team and pt were alerted. Pt was notified and pt denied any adverse reaction or symptoms. Pt was told to contact medical team if adverse reactions occured. Pt verbalized understanding.
Age: 59.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: States it feels hot, it's red, painful to move and itchy. Redness has spread all the way around underarm
Age: 38.0
Sex: F
Vaccine: UNK
Symptoms: Burning sensation
Clinical narrative: patient experiencing a burning sensation all over the body.
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered
Clinical narrative: The vaccine that was given is expired
Age: 56.0
Sex: F
Vaccine: HEP, PNC20
Symptoms: Injection site erythema, Injection site swelling, Pruritus, Rash
Clinical narrative: Patient was here for an appointment on 3/10/25 when vaccines were received. Patient stated that MA gave both into the same arm. Patient started itching this morning and noticed redness on arm. When I came to check on the reaction, patient has redness and swelling at injection site and all arm inside of arm down to her elbow. No fever, shortness of breath. Explained to her that this is a common reaction but gave another VIS sheet and discussed extreme reactions to contact doctor.
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Injection site erythema, Injection site nodule, Injection site warmth
Clinical narrative: Patient reported first noticed on Wednesday, 3/12, firm nodule on RT shoulder/deltoid with surrounding warmth and minor redness. Today (3/14/25) redness and warmth have resolved. RT firm nodule not tender or painful. Full active ROM without pain or tenderness. No s/sx of infection. Recommend warm compresses to site and f/u on Monday (3/17) if not continuing to improve.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness, Rash, Rash macular
Clinical narrative: pt felt flu like symptoms for 24 hours and then today noticed diffuse macular rash to chest, abdomen and back
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Dizziness, Hypotonia, Loss of consciousness, Pallor
Clinical narrative: Several minutes after receiving vaccines patient started walking out of room and became lightheaded.  Per doctor face and lips became pale.  Doctor caught her as she started to slump forward, she passed out 2-3 seconds while she was sat down on chair, she gasped and suddenly sat up and started speaking.  Facemask with 2L O2 applied.  Some coloring returned and walked back to room with assistance. Placed on exam table with legs up on wall in supine position. Over the next 5 minutes coloring returned to lips and cheeks.  Remained slightly lightheaded but answering questions appropriately.  Vital sign taken but nurse.  Mom remained in room with patient throughout event.  30 min later on follow up exam patient sitting up normally, normal exam.  Discharged in stable condition.
Age: 0.17
Sex: M
Vaccine: RV1
Symptoms: Intussusception, Urinary retention, Vomiting
Clinical narrative: Started vomiting 2 days later, did not have any wet diapers 2 days later
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: This writer administered the Covid Pfizer Vaccine at 2:10pm. At 2:20pm the patient reported SOB. Patient has hx of allergies to lobster, sumac, mold , osteoporosis medication, denied allergy to vaccine or vaccine component. Pt denied hives, itching, flushing, swollen lips/face/throat/eyes, denied nasal congestion, change in voice, sensation of throat closing, stridor, wheeze, cough, denied nausea, vomiting, cramping, abdominal pain, denied feeling dizzy, faint, heart racing. Pt reported SOB, that improved after taking 2 puffs of inhaler and took 2 doses of their benadryl which they had on hand. This writer stayed with the patient and observed for 60 minutes, I observed the patient ambulating throughout the house with 2 N95 masks on; no worsening of symptoms were observed. Pt remained alert and oriented for 60 minutes,  did not show signs of lethargy or struggling to breathe. Patient is known to me as this writer administered a homebound vaccine on 09/24.  I reviewed the Vaccine Information Sheet, specifically Step 5. When to Seek Medical Attention, signs/symptoms of anaphylaxis, when to call 9-1-1 and when to call PCP. Pt verbalized understanding. Pt reported symptoms of SOB had improved, patient alert, oriented. Pt had on hand their own 0.3mg EpiPen AutoInjector.  This writer reviewed the above information with the patient's spouse who was going to remain with the patient, who also verbalized understanding of when to seek medical care.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired vaccine was given. But there was no adverse reaction to the vaccination.
Age: 50.0
Sex: F
Vaccine: RSV
Symptoms: Wrong product administered
Clinical narrative: Patient here for her second Shingles vaccine.  Given the RSV vaccine.  VIS Shingles given.  Covering provider updated right away as well as RN supervisor updated.  Patient informed with 20 minutes of event.
Age: 21.0
Sex: F
Vaccine: COVID19, FLU3, MENB, MNQ, TDAP
Symptoms: Contraindication to vaccination, No adverse event
Clinical narrative: Client showed no adverse effects.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dyspnoea, Implantable cardiac monitor insertion, Pain in extremity, Palpitations
Clinical narrative: shortness of breath, heart palpitations, pain in lower back and along outside of thighs and legs
Age: 67.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site vesicles
Clinical narrative: The night of the vaccine the patient reports pain in the injection site, and then developed a red spot around the injection site. She drew a marker around it and then the redness expanded all the way down her arm and the injection site bubbled up with some fluid retention.
Age: 1.0
Sex: M
Vaccine: MMRV, PPV
Symptoms: Rash
Clinical narrative: Rash on thighs, back, face
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Product administered at inappropriate site
Clinical narrative: S- 50 year old, female calls clinic from work and states they received the shingles vaccination at their last drs appointment. Now pt is experiencing body aches & pain on right buttocks where she received the injection; along with a huge bump on it.       B- Pt had an office visit on 3/11/25 with Dr. for headache follow up. Pt received Zoster vaccine 0.5ml, IM, right gluete during appointment.       A- Pt states that she received shingles vaccine in her right butt check because her arms were too small. At vaccine injection site pt has a "goose egg" size hard lump. It's red but not hot to touch. Pt has been using heat & cold on lump. Heat works better. By utilizing heat and massage the lump goes down a little bit but comes right back an hour later. Pt states the lump hurts but it hurts like a bruise; can't lay down on right side. Pt feels like they have body aches all over their body and aches in their joints. Pt states that symptoms have been occurring since she received shingles vaccination. Pt has been taking 600mg Ibuprofen and 1,000 mg of Tylenol; medications have not really been helping pt. Pt denies hives, swelling of face or throat, difficulty breathing, heart palpitations, dizziness, or severe muscle weakness.              R- Based on pt symptoms ER or urgent care not indicated at this time. Will talk to provider about pt symptoms. Pt gave verbal ok for detailed message to be left on her phone. RN   Spoke with Dr. regarding pt's symptoms. Dr. states that this is an injection site reaction. This is your [pts] body's immune response to the vaccine. The lump is more noticeable because it is on the butt; It will go away. Keep taking pain medications as needed, stay hydrated (at least 8 cups of water per day) and rest. Lump should be gone by next Tuesday; by latest two weeks. Pt gave verbal ok for a detailed message to be left on her phone. This RN left voicemail on pt's phone communicating Dr.'s recommendations. RN
Age: 26.0
Sex: M
Vaccine: FLU3, IPV, TYP, YF
Symptoms: Immediate post-injection reaction, Vomiting
Clinical narrative: Pt presented for travel consultation and vaccines for a trip. He requested vaccination on typhoid, yellow fever, polio and flu. Offered pt administration of vaccines split between both arms or he could get all in 1 arm if he preferred. He requested all 4 in his left arm. Upon administration of 4 vaccines, pt briefly vomited into the trash can. This happened immediately after his last shot. Pt believes it may have been from his lunch and/or shot anxiety. He received 4 vaccines total: YF Vax Left back arm subQ, FluBlok2024-2025 Left delt top, Typhim left delt bottom left, and IPOL left delt bottom right all 1 inch apart. Post emesis, he drank about 8oz of water and said he felt fine. Pt was monitored for appox 30 min after vaccination before he left and said he felt great.
Vaccine: HPV9
Symptoms: Needle issue, No adverse event
Clinical narrative: No additional AE/PQC reported.; AE AND PRECAUTIONARY PQC FILED: HCP calling to report patient received less than recommended dose of GARDASIL 9 due to needle leakage while administering vaccine. Caller stated patient was receiving dose of GARDASIL 9 when leakage occurred, caller st; GARDASIL 9 due to  needle leakage while administering vaccine.; This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On 18-FEB-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant Injection (GARDASIL 9) lot # Y007322 and expiration date 18-AUG-2026 for prophylaxis (exact dose, dose number, route and site of administration were not provided). The patient received less than recommended dose of GARDASIL 9 due to needle leakage while administering vaccine (needle leakage and accidental underdose). Caller stated patient was receiving dose of GARDASIL 9 when leakage occurred, caller stated it was unknown if leakage was from a product defective or improperly attaching needle. Product was administered. No additional AE/PQC reported (no adverse event).